463 related articles for article (PubMed ID: 16800816)
21. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
[TBL] [Abstract][Full Text] [Related]
23. A feed-forward repression mechanism anchors the Sin3/histone deacetylase and N-CoR/SMRT corepressors on chromatin.
Vermeulen M; Walter W; Le Guezennec X; Kim J; Edayathumangalam RS; Lasonder E; Luger K; Roeder RG; Logie C; Berger SL; Stunnenberg HG
Mol Cell Biol; 2006 Jul; 26(14):5226-36. PubMed ID: 16809761
[TBL] [Abstract][Full Text] [Related]
24. Functional selectivity of recombinant mammalian SWI/SNF subunits.
Kadam S; McAlpine GS; Phelan ML; Kingston RE; Jones KA; Emerson BM
Genes Dev; 2000 Oct; 14(19):2441-51. PubMed ID: 11018012
[TBL] [Abstract][Full Text] [Related]
25. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors.
Xu R; Spencer VA; Bissell MJ
J Biol Chem; 2007 May; 282(20):14992-9. PubMed ID: 17387179
[TBL] [Abstract][Full Text] [Related]
28. Differential requirement of SWI/SNF for androgen receptor activity.
Marshall TW; Link KA; Petre-Draviam CE; Knudsen KE
J Biol Chem; 2003 Aug; 278(33):30605-13. PubMed ID: 12775722
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation.
Zhang B; Chambers KJ; Faller DV; Wang S
Oncogene; 2007 Nov; 26(50):7153-7. PubMed ID: 17486062
[TBL] [Abstract][Full Text] [Related]
31. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.
Wiley MM; Muthukumar V; Griffin TM; Griffin CT
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594
[TBL] [Abstract][Full Text] [Related]
32. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
Ito T; Watanabe H; Yamamichi N; Kondo S; Tando T; Haraguchi T; Mizutani T; Sakurai K; Fujita S; Izumi T; Isobe T; Iba H
Biochem J; 2008 Apr; 411(1):201-9. PubMed ID: 18042045
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
34. In vivo repression of an erythroid-specific gene by distinct corepressor complexes.
Rietveld LE; Caldenhoven E; Stunnenberg HG
EMBO J; 2002 Mar; 21(6):1389-97. PubMed ID: 11889044
[TBL] [Abstract][Full Text] [Related]
35. Sas3 and Ada2(Gcn5)-dependent histone H3 acetylation is required for transcription elongation at the de-repressed FLO1 gene.
Church M; Smith KC; Alhussain MM; Pennings S; Fleming AB
Nucleic Acids Res; 2017 May; 45(8):4413-4430. PubMed ID: 28115623
[TBL] [Abstract][Full Text] [Related]
36. The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.
Trotter KW; Fan HY; Ivey ML; Kingston RE; Archer TK
Mol Cell Biol; 2008 Feb; 28(4):1413-26. PubMed ID: 18086889
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
38. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.
Marathe HG; Mehta G; Zhang X; Datar I; Mehrotra A; Yeung KC; de la Serna IL
PLoS One; 2013; 8(7):e69037. PubMed ID: 23874858
[TBL] [Abstract][Full Text] [Related]
39. BRG1 Governs Nanog Transcription in Early Mouse Embryos and Embryonic Stem Cells via Antagonism of Histone H3 Lysine 9/14 Acetylation.
Carey TS; Cao Z; Choi I; Ganguly A; Wilson CA; Paul S; Knott JG
Mol Cell Biol; 2015 Dec; 35(24):4158-69. PubMed ID: 26416882
[TBL] [Abstract][Full Text] [Related]
40. A novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression.
Zhang M; Fang H; Zhou J; Herring BP
J Biol Chem; 2007 Aug; 282(35):25708-16. PubMed ID: 17599918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
